Western Sahara Health Bulletin: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Western Sahara Health Bulletin.

Press releases published on October 21, 2026

4 hours ago

Cerenome Announces New Dual Mechanism of Action Featuring Lethal DNA Damage and Beneficial Immunomodulation Supporting Lead Investigational Drug REYOBIQ™ 

Indeterminate GlobeNewswire

4 hours ago

Kyverna Therapeutics Presents Full One-Year Registrational Data Set Demonstrating Sustained Clinical Benefit of Miv-cel in Stiff Person Syndrome at MS Toronto

Indeterminate GlobeNewswire

4 hours ago

INmune Bio Advances Ebstrocel™ Toward Potential UK Approval in Mid-2027

Indeterminate GlobeNewswire

4 hours ago

Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission and PDUFA Date of March 25, 2027

Indeterminate GlobeNewswire

4 hours ago

Invivyd Presents VMS063, a Potential Best-in-Class Monoclonal Antibody Candidate for the Treatment and Prevention of Measles, at IDWeek 2026

Indeterminate GlobeNewswire

4 hours ago

Sitryx to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

4 hours ago

Peptide Manufacturing Trends: How Oral Dosing Raises API Demand

Indeterminate GlobeNewswire

4 hours ago

Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met

Indeterminate GlobeNewswire

4 hours ago

Tiziana Management Team to Attend the 10th Joint ACTRIMS-ECTRIMS Meeting in Toronto

Indeterminate GlobeNewswire

4 hours ago

Elion Therapeutics to Present Turletricin Clinical Data at IDWeek 2026

Indeterminate GlobeNewswire

4 hours ago

Opus Genetics Announces FDA Clearance of IND Application for OPGx-RDH12 Gene Therapy for Inherited Childhood Blindness

Indeterminate GlobeNewswire

4 hours ago

Satellos to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

4 hours ago

Entrada Therapeutics Appoints Linea Aspesi as Chief People Officer

Indeterminate GlobeNewswire

4 hours ago

Jade Biosciences to Highlight Advancement of JADE101 Development Program at American Society of Nephrology (ASN) Kidney Week 2026

Indeterminate GlobeNewswire

4 hours ago

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026

Indeterminate GlobeNewswire

4 hours ago

West Ham United F.C. and BrewDog Unveil Boleyn Brew: A Fan-Created Matchday Beer Made by Hammers, for Hammers

Indeterminate GlobeNewswire

4 hours ago

INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar

Indeterminate GlobeNewswire

4 hours ago

What joint replacement involves, from the surgeon's credentials to the recovery plan

Indeterminate GlobeNewswire

4 hours ago

Sundance Biosciences Announces Presentation of Phase 1 Results for SUN-627, a Brain-Penetrant TYK2 Inhibitor for the Treatment of Multiple Sclerosis (MS)

Indeterminate GlobeNewswire

4 hours ago

Sotera Health Announces Third-Quarter 2026 Earnings Release Date

Indeterminate GlobeNewswire